Apellis Pharmaceuticals Inc
NASDAQ:APLS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Apellis Pharmaceuticals Inc
NASDAQ:APLS
|
US |
|
P
|
Pennon Group PLC
OTC:PEGRF
|
UK |
Intrinsic Value
The intrinsic value for
Apellis Pharmaceuticals Inc (APLS) under the Base Case is 35.23 USD.
Compared with the current market price of 41.03 USD, the stock appears
Overvalued by 14% .
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Apellis Pharmaceuticals Inc.
Fundamental Analysis
Revenue & Expenses Breakdown
Apellis Pharmaceuticals Inc
Earnings Waterfall
Apellis Pharmaceuticals Inc
The intrinsic value for
Apellis Pharmaceuticals Inc (APLS) under the Base Case is 35.23 USD.
Compared with the current market price of 41.03 USD, the stock appears Overvalued by 14% .